The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Exosome Therapy Market Research Report 2024

Global Exosome Therapy Market Research Report 2024

Publishing Date : Apr, 2022

License Type :
 

Report Code : 1692661

No of Pages : 86

Synopsis
Market Analysis and Insights: Global Exosome Therapy Market
Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Direct Treatment accounting for % of the Exosome Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Exosome Therapy market size is valued at US$ million in 2021, while the North America and Europe Exosome Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Exosome Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Therapy market.
Global Exosome Therapy Scope and Market Size
Exosome Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Exosome Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Direct Treatment
Drug Delivery Vehicle
Segment by Application
Hospital
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
United Therapeutics Corporation
Codiak BioSciences
EngEx™
Esperite Group
ArunA Biomedical
Evox Therapeutics
NeurExo Sciences
Tavec Pharmaceuticals
AEGLE Therapeutics
Avalon GloboCare
AlligatorBioscience
Capricor Therapeutics
Stem Cell Medicine
CellTex Therapeutics
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2017-2028)
2.2 Exosome Therapy Growth Trends by Region
2.2.1 Exosome Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Exosome Therapy Historic Market Size by Region (2017-2022)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2023-2028)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Players by Revenue
3.1.1 Global Top Exosome Therapy Players by Revenue (2017-2022)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Revenue
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2021
3.5 Exosome Therapy Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Product Solution and Service
3.7 Date of Enter into Exosome Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2017-2022)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2023-2028)
5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2017-2022)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Exosome Therapy Market Size (2017-2028)
6.2 North America Exosome Therapy Market Size by Country (2017-2022)
6.3 North America Exosome Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Exosome Therapy Market Size (2017-2028)
7.2 Europe Exosome Therapy Market Size by Country (2017-2022)
7.3 Europe Exosome Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Market Size (2017-2028)
8.2 Asia-Pacific Exosome Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Exosome Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Exosome Therapy Market Size (2017-2028)
9.2 Latin America Exosome Therapy Market Size by Country (2017-2022)
9.3 Latin America Exosome Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Market Size (2017-2028)
10.2 Middle East & Africa Exosome Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Exosome Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Detail
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022)
11.1.5 United Therapeutics Corporation Recent Development
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Detail
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022)
11.2.5 Codiak BioSciences Recent Development
11.3 EngEx™
11.3.1 EngEx™ Company Detail
11.3.2 EngEx™ Business Overview
11.3.3 EngEx™ Exosome Therapy Introduction
11.3.4 EngEx™ Revenue in Exosome Therapy Business (2017-2022)
11.3.5 EngEx™ Recent Development
11.4 Esperite Group
11.4.1 Esperite Group Company Detail
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2017-2022)
11.4.5 Esperite Group Recent Development
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Detail
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022)
11.5.5 ArunA Biomedical Recent Development
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Detail
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.6.5 Evox Therapeutics Recent Development
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Detail
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022)
11.7.5 NeurExo Sciences Recent Development
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Detail
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022)
11.8.5 Tavec Pharmaceuticals Recent Development
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Detail
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.9.5 AEGLE Therapeutics Recent Development
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Detail
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022)
11.10.5 Avalon GloboCare Recent Development
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Detail
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022)
11.11.5 AlligatorBioscience Recent Development
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Detail
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.12.5 Capricor Therapeutics Recent Development
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Detail
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022)
11.13.5 Stem Cell Medicine Recent Development
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Detail
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.14.5 CellTex Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Exosome Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Direct Treatment
Table 3. Key Players of Drug Delivery Vehicle
Table 4. Global Exosome Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Exosome Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Exosome Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Exosome Therapy Market Share by Region (2017-2022)
Table 8. Global Exosome Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Exosome Therapy Market Share by Region (2023-2028)
Table 10. Exosome Therapy Market Trends
Table 11. Exosome Therapy Market Drivers
Table 12. Exosome Therapy Market Challenges
Table 13. Exosome Therapy Market Restraints
Table 14. Global Exosome Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Exosome Therapy Market Share by Players (2017-2022)
Table 16. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2021)
Table 17. Ranking of Global Top Exosome Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Exosome Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exosome Therapy Product Solution and Service
Table 21. Date of Enter into Exosome Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Exosome Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Exosome Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Exosome Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Exosome Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global Exosome Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Exosome Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Exosome Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Exosome Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. United Therapeutics Corporation Company Detail
Table 42. United Therapeutics Corporation Business Overview
Table 43. United Therapeutics Corporation Exosome Therapy Product
Table 44. United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 45. United Therapeutics Corporation Recent Development
Table 46. Codiak BioSciences Company Detail
Table 47. Codiak BioSciences Business Overview
Table 48. Codiak BioSciences Exosome Therapy Product
Table 49. Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 50. Codiak BioSciences Recent Development
Table 51. EngEx™ Company Detail
Table 52. EngEx™ Business Overview
Table 53. EngEx™ Exosome Therapy Product
Table 54. EngEx™ Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 55. EngEx™ Recent Development
Table 56. Esperite Group Company Detail
Table 57. Esperite Group Business Overview
Table 58. Esperite Group Exosome Therapy Product
Table 59. Esperite Group Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 60. Esperite Group Recent Development
Table 61. ArunA Biomedical Company Detail
Table 62. ArunA Biomedical Business Overview
Table 63. ArunA Biomedical Exosome Therapy Product
Table 64. ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 65. ArunA Biomedical Recent Development
Table 66. Evox Therapeutics Company Detail
Table 67. Evox Therapeutics Business Overview
Table 68. Evox Therapeutics Exosome Therapy Product
Table 69. Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 70. Evox Therapeutics Recent Development
Table 71. NeurExo Sciences Company Detail
Table 72. NeurExo Sciences Business Overview
Table 73. NeurExo Sciences Exosome Therapy Product
Table 74. NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 75. NeurExo Sciences Recent Development
Table 76. Tavec Pharmaceuticals Company Detail
Table 77. Tavec Pharmaceuticals Business Overview
Table 78. Tavec Pharmaceuticals Exosome Therapy Product
Table 79. Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 80. Tavec Pharmaceuticals Recent Development
Table 81. AEGLE Therapeutics Company Detail
Table 82. AEGLE Therapeutics Business Overview
Table 83. AEGLE Therapeutics Exosome Therapy Product
Table 84. AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 85. AEGLE Therapeutics Recent Development
Table 86. Avalon GloboCare Company Detail
Table 87. Avalon GloboCare Business Overview
Table 88. Avalon GloboCare Exosome Therapy Product
Table 89. Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 90. Avalon GloboCare Recent Development
Table 91. AlligatorBioscience Company Detail
Table 92. AlligatorBioscience Business Overview
Table 93. AlligatorBioscience Exosome TherapyProduct
Table 94. AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 95. AlligatorBioscience Recent Development
Table 96. Capricor Therapeutics Company Detail
Table 97. Capricor Therapeutics Business Overview
Table 98. Capricor Therapeutics Exosome TherapyProduct
Table 99. Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 100. Capricor Therapeutics Recent Development
Table 101. Stem Cell Medicine Company Detail
Table 102. Stem Cell Medicine Business Overview
Table 103. Stem Cell Medicine Exosome TherapyProduct
Table 104. Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 105. Stem Cell Medicine Recent Development
Table 106. CellTex Therapeutics Company Detail
Table 107. CellTex Therapeutics Business Overview
Table 108. CellTex Therapeutics Exosome TherapyProduct
Table 109. CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 110. CellTex Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapy Market Share by Type: 2021 VS 2028
Figure 2. Direct Treatment Features
Figure 3. Drug Delivery Vehicle Features
Figure 4. Global Exosome Therapy Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Exosome Therapy Report Years Considered
Figure 9. Global Exosome Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Exosome Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Exosome Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Exosome Therapy Market Share by Players in 2021
Figure 13. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Exosome Therapy Revenue in 2021
Figure 15. North America Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Exosome Therapy Market Share by Country (2017-2028)
Figure 17. United States Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Exosome Therapy Market Share by Country (2017-2028)
Figure 21. Germany Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Exosome Therapy Market Share by Region (2017-2028)
Figure 29. China Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Exosome Therapy Market Share by Country (2017-2028)
Figure 37. Mexico Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Exosome Therapy Market Share by Country (2017-2028)
Figure 41. Turkey Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. United Therapeutics Corporation Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 44. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 45. EngEx™ Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 46. Esperite Group Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 47. ArunA Biomedical Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 48. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 49. NeurExo Sciences Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 50. Tavec Pharmaceuticals Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 51. AEGLE Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 52. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 53. AlligatorBioscience Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 54. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 55. Stem Cell Medicine Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 56. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’